Let us help you with your inquiries, brochures and pricing requirements Request A Quote Download PDF Copy Request A Quote Download PDF Copy Request A Quote Download ...
Attrition in the therapeutic pipeline can often be associated with the lack of translational efficacy from the pre-clinical phase to the clinic. Organoids demonstrate the significant potential to ...
The Automation Partnership (TAP) has announced CompacT SelecT™ automated cell culture system has been installed at a prestigious, new US defence facility, to produce high quality cell lines in ...
Attrition in the therapeutic pipeline can typically result from a lack of translational efficacy between the pre-clinical phase and the clinic. Organoids offer much promise in drug screening and ...
Opportunities include the growing demand for scalable solutions to support the burgeoning cell and gene therapy pipeline, ...
The Mytos automated cell culture system can produce a range of intricate cell types from brain to heart cells within a matter of weeks. Beginning with stem cells (iPSCs), the system can efficiently ...
The BioProfile FLEX2 combines Nova Biomedical’s microsensor card technology with optical measurement and freezing point osmometry to provide an automated cell culture analyzer that can eliminate ...
Cell Counting Imager (CCI), a custom device that measures cell concentrations in 8 samples at once, to calculate the appropriate volumes of cell suspension needed to seed a specified number of cells ...
TAP Biosystems has announced a new NCI 60 application for its CompacT SelecT™, a system that automates cell culture and processing in T-flasks and microplates. The details of the application, which ...
An automated cell culture system reduces hands-on time and improves seeding consistency in 96-well microplates. The research is published in the journal PNAS Nexus. Manuel Leonetti, Rafael ...
LONDON--(BUSINESS WIRE)--Mytos, an innovative leader in automated cell manufacturing, announced today it has closed $19M in Series A financing led by Buckley Ventures, with participation from IQ ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results